IRIS UniCatt

Morganti, Alessio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.558
NA - Nord America 6.681
AS - Asia 2.845
SA - Sud America 253
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 15
Totale 17.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.549
DE - Germania 3.244
SE - Svezia 1.365
SG - Singapore 1.051
CN - Cina 1.002
UA - Ucraina 633
IT - Italia 596
FR - Francia 343
IE - Irlanda 334
GB - Regno Unito 279
IN - India 254
BR - Brasile 224
ID - Indonesia 215
FI - Finlandia 199
PL - Polonia 151
RU - Federazione Russa 130
CA - Canada 114
TR - Turchia 107
BE - Belgio 75
CI - Costa d'Avorio 65
CZ - Repubblica Ceca 54
NL - Olanda 42
HK - Hong Kong 40
JP - Giappone 38
IR - Iran 32
AT - Austria 19
VN - Vietnam 19
AU - Australia 12
EU - Europa 12
EG - Egitto 11
LT - Lituania 11
RO - Romania 11
ES - Italia 10
CH - Svizzera 9
PT - Portogallo 9
AZ - Azerbaigian 8
IL - Israele 8
MX - Messico 8
AR - Argentina 7
CL - Cile 7
LK - Sri Lanka 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
IQ - Iraq 5
JO - Giordania 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
MA - Marocco 5
PA - Panama 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
DK - Danimarca 4
EC - Ecuador 4
HU - Ungheria 4
KG - Kirghizistan 4
NO - Norvegia 4
AL - Albania 3
BD - Bangladesh 3
BO - Bolivia 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
ZA - Sudafrica 3
A1 - Anonimo 2
BG - Bulgaria 2
CO - Colombia 2
EE - Estonia 2
JM - Giamaica 2
KE - Kenya 2
MK - Macedonia 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
BZ - Belize 1
CM - Camerun 1
KR - Corea 1
MD - Moldavia 1
PR - Porto Rico 1
SI - Slovenia 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 17.458
Salva come PNG Salva come JPEG
Città #
Chandler 1.538
Singapore 618
Ashburn 509
Jacksonville 385
Dublin 332
San Mateo 310
Nanjing 230
Dearborn 216
Ann Arbor 215
Jakarta 213
Wilmington 192
Nürnberg 183
Woodbridge 153
New York 149
Boston 147
Warsaw 146
Milan 133
Bremen 127
Marseille 118
Beijing 104
Lawrence 103
Izmir 101
Nanchang 92
Hyderabad 91
Cattolica 89
Princeton 85
Moscow 84
Houston 80
Los Angeles 80
Helsinki 78
Fairfield 77
Munich 77
Brussels 75
Redwood City 71
Abidjan 65
Seattle 64
Rome 63
Leawood 61
Toronto 52
Frankfurt am Main 44
Zhengzhou 44
North York 42
Boardman 41
University Park 39
Kunming 38
Shenyang 37
Düsseldorf 36
Hebei 36
Jiaxing 35
Augusta 34
Fremont 32
Changsha 29
Tianjin 29
Phoenixville 28
The Dalles 28
Cambridge 27
Guangzhou 27
Hong Kong 27
Mountain View 26
Norwalk 26
Detroit 24
Lancaster 24
Shanghai 24
Auburn Hills 23
Hangzhou 22
Brno 21
Pune 21
Lauterbourg 19
Nuremberg 19
São Paulo 19
Washington 19
Falls Church 18
London 18
Amsterdam 16
Redmond 16
Hanoi 15
Monmouth Junction 15
Edinburgh 13
Lanzhou 13
Enterprise 12
Andover 11
Falkenstein 11
Hefei 11
Jinan 11
Ottawa 11
Portsmouth 11
Bologna 10
Ardabil 9
Cairo 9
Chicago 9
Indiana 9
San Francisco 9
Vienna 9
Wuhan 9
Baku 8
Council Bluffs 8
Dresden 8
Mumbai 8
North Bergen 8
Sacramento 8
Totale 8.769
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 805
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 258
A National project for in vivo dosimetry procedures in radiotherapy: First results 255
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 254
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 178
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 177
A National project for in vivo dosimetry procedures in radiotherapy: First results 174
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 171
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 169
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 154
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 153
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 153
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 149
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 147
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 146
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 144
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 144
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 143
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 140
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 138
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 137
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 137
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 137
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 136
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 136
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 136
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 134
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 134
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 132
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 131
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 131
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 131
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 131
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 128
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 127
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 125
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 124
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 122
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 121
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 121
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 120
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 119
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 118
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 118
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 117
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 117
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 117
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 115
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 115
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 114
In Vivo Portal Dosimetry by an Ionization Chamber 113
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 113
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 112
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 112
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 108
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 108
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 108
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 107
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 106
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 105
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 104
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 104
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 104
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 104
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 103
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 103
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 103
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 102
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 101
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 101
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 99
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 97
Real time transit dosimetry for the breath-hold radiotherapy technique experience 96
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 96
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 95
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 94
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 94
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 93
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 92
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 91
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 91
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 90
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 90
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 90
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 88
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 88
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 88
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 88
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 87
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 87
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 87
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 86
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 85
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 84
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 83
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 83
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 83
Preoperative chemoradiation with raltitrexed (Tomudex) in T2/N+ and T3/N+ rectal cancers: a phase I study. 82
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 81
Totale 12.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020428 0 0 0 0 0 0 0 0 0 0 265 163
2020/20211.452 81 171 30 156 204 64 140 42 167 107 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/20252.500 107 98 253 141 430 95 83 186 658 435 14 0
Totale 18.140